levofloxacin has been researched along with Keratitis in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (35.71) | 29.6817 |
2010's | 12 (42.86) | 24.3611 |
2020's | 6 (21.43) | 2.80 |
Authors | Studies |
---|---|
Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Ren, L; Sin, WLW; Tan, DTH; Wang, L; Zhou, L | 1 |
Ide, T; Kato, N; Kobashi, H; Toda, I | 1 |
Bhamare, P; Dunman, PM; Johnson, W; Kinn, B; Laskey, E; Mei, JA; Nolin, L; Stalker, C; Wozniak, RAF | 1 |
Khan, M; Ma, K; Wan, I; Willcox, MD | 1 |
Borde, P; Meena, AK; Parmar, GS; Prasad, S | 1 |
Chen, WD; Hsu, WH; Huang, TY; Lai, LJ | 1 |
Jiang, M; Li, G; Wu, X; Xu, L | 1 |
Chang, YF; Cheng, YH; Ko, YC; Liu, CJ | 1 |
Lee, WH; Li, SA; Liu, J; Wang, YJ; Xiang, Y; Zhang, Y | 1 |
Fujita, K; Goto, H; Hattori, T; Ito, N; Koike, N; Kumakura, S; Kuroda, M; Matsumoto, T; Miyake, T; Tajima, K; Yamaguchi, T | 1 |
Guo, C; Han, S; Jiang, H; Liu, T; Wu, X | 1 |
Hassan, A; Hoffman, J | 1 |
Fujita, K; Goto, H; Hattori, T; Ito, N; Koike, N; Kuroda, M; Matsumoto, T; Miyake, T; Tajima, K; Takahashi, H | 1 |
Chauhan, A; Colaço, R; Paradiso, P; Saramago, B; Serro, AP | 1 |
Eguchi, H; Hotta, F; Ishimaru, M; Kogiso, M; Kusaka, S; Nishimura, K; Shimomura, Y; Yaguchi, T | 1 |
Scoper, SV | 1 |
Chen, H; Jiang, HR; Wu, XG; Xin, M; Yang, LN | 1 |
Chen, H; Jiang, H; Liu, T; Song, Z; Wu, X; Xu, Y; Yang, L; Yue, W | 1 |
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
Chen, F; Hu, Y; Zhang, M | 1 |
Carpenter, TR; Kaufman, MB; McDonnell, PJ; Sarayba, MA; Sweet, PM; Taban, M; Tungsiripat, T | 1 |
Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC | 1 |
Alfonso, EC; Miller, D | 1 |
Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA; Traidej, M | 1 |
Caballero, AR; Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
Graff, JM; Kesler-Diaz, A; McDonnell, PJ; Osann, KE; Reiser, BJ; Sarayba, MA; Shamie, N; Sweet, PM; Taban, M | 1 |
Inoue, T; Kida, T; Naka, H; Sakaki, H; Tokushige, H; Wada, T | 1 |
Gordon, YJ; Husted, RC; Karenchak, LM; Kowalski, RP; Pandya, AN; Ritterband, DC; Romanowski, EG; Shah, MK | 1 |
1 review(s) available for levofloxacin and Keratitis
Article | Year |
---|---|
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Endophthalmitis; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmology; Quinolines | 2008 |
1 trial(s) available for levofloxacin and Keratitis
Article | Year |
---|---|
[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Female; Humans; Keratitis; Levofloxacin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions | 2000 |
26 other study(ies) available for levofloxacin and Keratitis
Article | Year |
---|---|
Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
Topics: Animals; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell Survival; Drug Resistance, Bacterial; Fibroblasts; Flavones; Hemolysis; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Mimicry; Rabbits; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Infectious keratitis after corneal crosslinking for keratoconus caused by levofloxacin-resistant microorganisms.
Topics: Cornea; Cross-Linking Reagents; Female; Humans; Keratitis; Keratoconus; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Photosensitizing Agents; Retrospective Studies; Riboflavin | 2021 |
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
Topics: Anti-Bacterial Agents; Bacitracin; Drug Combinations; Erythromycin; Framycetin; Humans; Keratitis; Levofloxacin; Moxifloxacin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Tobramycin; Trimethoprim | 2022 |
Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Topics: Agar; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Gentamicins; Humans; Imipenem; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Microbial keratitis and antibiotic sensitivity patterns: A retrospective analysis at a tertiary center in Central India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Erythromycin; Eye Infections, Bacterial; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Vibrio cholerae non-O1 - the first reported case of keratitis in a healthy patient.
Topics: Administration, Topical; Amikacin; Anti-Bacterial Agents; Aquatic Organisms; Corneal Ulcer; Eye; Humans; Keratitis; Levofloxacin; Male; Middle Aged; Polymerase Chain Reaction; Seawater; Treatment Outcome; Vibrio cholerae non-O1; Vibrio Infections | 2019 |
Eye drops and eye gels of levofloxacin: comparison of ocular absorption characterizations and therapeutic effects in the treatment of bacterial keratitis in rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Gels; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ocular Absorption; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Chitosan; Cytokines; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Therapy, Combination; Endophthalmitis; Epithelial Cells; Epithelium, Corneal; Hydrogels; Keratitis; Levofloxacin; Nanoparticles; Particle Size; Postoperative Complications; Prednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Temperature | 2021 |
Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Cationic Peptides; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Eye Infections, Bacterial; Gentamicins; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2014 |
In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
Topics: Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2014 |
In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Severe staphylococcal marginal keratitis presenting with hypopyon.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Iridocyclitis; Keratitis; Levofloxacin; Staphylococcal Infections; Ultrasonography | 2015 |
Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Keratitis; Levofloxacin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2015 |
Controlled Release of Antibiotics From Vitamin E-Loaded Silicone-Hydrogel Contact Lenses.
Topics: Anti-Bacterial Agents; Chlorhexidine; Contact Lenses, Hydrophilic; Delayed-Action Preparations; Diffusion; Drug Delivery Systems; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Keratitis; Levofloxacin; Ophthalmic Solutions; Silicones; Vitamin E | 2016 |
A super-infection in the cornea caused by Stemphylium, Acremonium, and α-Streptococcus.
Topics: Acremonium; Aged; Anti-Infective Agents; Cefmenoxime; Coinfection; Cornea; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Moxifloxacin; Saccharomycetales; Streptococcus | 2017 |
Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis.
Topics: Absorption; Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Bacterial Load; Biological Availability; Cell Line; Cell Proliferation; Cornea; Disease Models, Animal; Endothelial Cells; Eye; Female; Humans; Keratitis; Levofloxacin; Male; Ofloxacin; Ophthalmic Solutions; Orchidaceae; Plant Extracts; Polysaccharides; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tears; Treatment Outcome | 2010 |
Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents, Local; Colony Count, Microbial; Conjunctival Diseases; Cornea; Eye; Female; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2012 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Keratomileusis, Laser In Situ; Levofloxacin; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps | 2003 |
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Endophthalmitis; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Viridans Streptococci | 2004 |
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cornea; Drug Resistance, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Staphylococcal Infections | 2004 |
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Serratia Infections; Serratia marcescens | 2004 |
Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Transplantation; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rabbits | 2005 |
Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis.
Topics: Animals; Anti-Inflammatory Agents; Aza Compounds; Cells, Cultured; Conjunctivitis; Endotoxins; Fluoroquinolones; Gatifloxacin; Immunologic Factors; Keratitis; Levofloxacin; Lipopolysaccharides; Macrophages, Peritoneal; Male; Methicillin Resistance; Mice; Mice, Inbred C3H; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tumor Necrosis Factor-alpha | 2008 |
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Eye Infections, Bacterial; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Time Factors | 2001 |